NorthCrest Asset Manangement’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Sell |
1,380
-9
| -0.6% | -$4.14K | 0.02% | 375 |
|
|
2025
Q1 | $673K | Buy |
1,389
+96
| +7% | +$46.5K | 0.02% | 369 |
|
|
2024
Q4 | $521K | Sell |
1,293
-125
| -9% | -$50.4K | 0.02% | 388 |
|
|
2024
Q3 | $660K | Buy |
1,418
+188
| +15% | +$87.5K | 0.02% | 360 |
|
|
2024
Q2 | $577K | Buy |
1,230
+294
| +31% | +$138K | 0.02% | 360 |
|
|
2024
Q1 | $391K | Buy |
936
+107
| +13% | +$44.7K | 0.01% | 413 |
|
|
2023
Q4 | $337K | Sell |
829
-451
| -35% | -$184K | 0.01% | 437 |
|
|
2023
Q3 | $445K | Sell |
1,280
-14
| -1% | -$4.87K | 0.02% | 385 |
|
|
2023
Q2 | $455K | Buy |
1,294
+6
| +0.5% | +$2.11K | 0.02% | 376 |
|
|
2023
Q1 | $406K | Sell |
1,288
-23
| -2% | -$7.25K | 0.02% | 399 |
|
|
2022
Q4 | $379K | Buy |
+1,311
| New | +$379K | 0.02% | 329 |
|